Sanofi

Driven by the pursuit of scientific miracles, Sanofi places innovation at the heart of its mission to improve patients' lives, with the goal of "going further and faster for patients." A major global player in healthcare, the company is deploying cutting-edge scientific advances in five key therapeutic areas: immunology and inflammation, rare diseases and rare blood disorders, neurology, vaccines, and oncology. Guided by the resilience of patients and caregivers, Sanofi harnesses the power of science and innovative technologies, including artificial intelligence, to develop treatments and vaccines that address essential health needs.
Anchored in France, where part of its R&D and industrial activities are based, Sanofi is developing a robust scientific ecosystem. Its teams collaborate with institutions of excellence such as INSERM, the Pasteur Institute, university hospitals, and academic and biotech partners, contributing to the emergence of tomorrow's medicine.
Beyond scientific innovation, Sanofi has a strong social ambition to strengthen equitable access to healthcare, particularly for vulnerable populations, reduce the environmental impact of its activities, and contribute to more resilient healthcare systems. In France, this commitment is reflected in concrete actions: partnerships to improve access to healthcare for people in precarious situations, the "Planet Care" program to reduce environmental impact, and initiatives to promote a more inclusive society.
Through all of its actions, Sanofi reaffirms its role as a responsible company, guided by exemplary ethical conduct and a vision firmly focused on having a positive impact on patients, the planet, and society.